CasNo.171228-49-2,98% up GMP DMF Posaconazole 171228-49-2,(171228-49-2) Suppliers

1 Kilogram	Negotiable

Min.Order :1 Kilogram
Purity: 98% up
Payment Terms : L/C,T/T,Other

Keywords

Posaconazole Posaconazole powder 171228-49-2

Quick Details

Appearance:White crystallization
Application:antifungal.
PackAge:25kg/drum
ProductionCapacity:10|Metric Ton|Day
Storage:room temperature
Transportation:AIR SEA TRAIN

Superiority:

We are very compeitive on Posaconazole.Our mfr is GMP certified for this item with DMF document.

Product Name:	Posaconazole
CAS:	171228-49-2
MF:	C37H42F2N8O4
MW:	700.78
EINECS:	682-747-8
Product Categories:	API;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals;Inhibitors
Mol File:	171228-49-2.mol

Details:

Product name	Posaconazole
CAS No.	171228-49-2
Molecular Formula	C₃₇H₄₂F₂N₈O₄
Molecular Weight	700.78
Quality Standard	98% up by HPLC, DMF
Appearance	White to off-white powder

ITEMS	SPECIFICATION	RESULT
Appearance	White to off-white powder	Conforms
Melting point	167 ?171°C	167.5 ?168.0°C
Specific optical rotation	-28.5°?-24.5° The retention time of the major peak of the test	-27.2°
Identity	The retention time of the major peak of the test solution corresponds to that of the standard solution, as obtained in the Assay.	Conforms
Identity	The infrared absorption spectrum of this product should corresponds to the reference spectrum.	Conforms
Crystallinity	There are characteristic peaks at 7.7°±0.2°,9.9°±0.2°, 17.8°±0.2°, 19.5°±0.2°, 20.0°± 0.2°(Crystal form 1).	Conforms
Water content (%w/w)	≤0.5%	0.1%
Residue on ignition	≤0.1%	0.02%
Related substances	QR0005DS-IN-01: ≤0.10% QR0005DS-IN-02: ≤0.10% QR0005DS-IM-08: ≤0.10% QR0005DS-IM-06: ≤0.10% Other maximum unknown impurity ≤0.10% Total impurities: ≤0.40%	Not detected 0.01% Not detected Not detected 0.02% 0.07%
Enantiomeric and diastereoisomer	QR0005DS-IM-02: ≤0.10% QR0005DS-IM-03: ≤0.10% QR0005DS-IM-04: ≤0.10% QR0005DS-IM-01+QR0005DS-IM-05+ QR0005DS-IM-06: ≤0.10% QR0005DS-IM-07 ≤0.10% Total isomer impurities: ≤0.50%	0.01% Not detected Not detected Not detected Not detected 0.02% 0.04%
Residual solvents	Methanol: ≤3000 ppm Dichloromethane: ≤600 ppm Acetone: ≤5000 ppm Ethanol: ≤5000 ppm Dimethyl sulfoxide: ≤5000 ppm	31 ppm 53 ppm Not detected Not detected Not detected
Benzene	≤2 ppm	Not detected
Heavy metals	≤10 ppm	Conforms
Bacterial endotoxin	≤0.25 EU/mg	Conforms
Microbial limit	Total Aerobic Microbial Count (TAMC): ≤102 cfu/g Total molds and Yeast Count (TYMC): ≤101cfu/g Escherichia Coli: Absence	10 cfu/g < 10 cfu/g Not detected
Assay	C37H42F2N8O4： 98.0% ?102.0% (on the anhydrous basis)	101.0%
Conclusion	Conform to Enterprise Standard

Function of Posaconazole

Posaconazole is a triazole antifungal drug, which can inhibit the synthesis of fungal cell membranes, thereby producing antifungal effects. It can mainly be used to prevent invasive Aspergillus and Candida infections, and is suitable for the prevention of acute Aspergillus and Candida infections caused by severe immunodeficiency in patients 13 years of age and older.

After the above patients received hematopoietic stem cell transplantation, patients with graft-versus-host disease, or patients with hematological malignancies with prolonged neutropenia caused by chemotherapy, so this drug is mainly used to prevent invasive Aspergillus and Candida Infection.